AXIM Biotechnologies AXIM Stock
AXIM Biotechnologies Price Chart
AXIM Biotechnologies AXIM Financial and Trading Overview
| AXIM Biotechnologies stock price | 0.0050 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.03 - 0.04 USD |
| 52 Week Range | 0.02 - 0.13 USD |
| Volume | 344.77K USD |
| Avg. Volume | 323.38K USD |
| Market Cap | 7.51M USD |
| Beta (5Y Monthly) | 1.519014 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AXIM Valuation Measures
| Enterprise Value | 12.35M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 461.6775 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 758.949 |
| Enterprise Value/EBITDA | -3.246 |
Trading Information
AXIM Biotechnologies Stock Price History
| Beta (5Y Monthly) | 1.519014 |
| 52-Week Change | -46.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.13 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.04 USD |
AXIM Share Statistics
| Avg. Volume (3 month) | 323.38K USD |
| Avg. Daily Volume (10-Days) | 231.57K USD |
| Shares Outstanding | 227.65M |
| Float | 149.09M |
| Short Ratio | N/A |
| % Held by Insiders | 33.33% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -25998.34% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -58.062% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 16.27K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 8.88K USD |
| EBITDA | -3804097 USD |
| Net Income Avi to Common (ttm) | -6918863 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 53.54K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 5.35M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.012 |
| Book Value Per Share (mrq) | -0.028 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1482568 USD |
| Levered Free Cash Flow (ttm) | 886.4K USD |
Profile of AXIM Biotechnologies
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 6191 Cornerstone Court, East |
| ZIP | 92121 |
| Phone | 858-923-4422 |
| Website | https://www.aximbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
Q&A For AXIM Biotechnologies Stock
What is a current AXIM stock price?
AXIM Biotechnologies AXIM stock price today per share is 0.0050 USD.
How to purchase AXIM Biotechnologies stock?
You can buy AXIM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AXIM Biotechnologies?
The stock symbol or ticker of AXIM Biotechnologies is AXIM.
Which industry does the AXIM Biotechnologies company belong to?
The AXIM Biotechnologies industry is Biotechnology.
How many shares does AXIM Biotechnologies have in circulation?
The max supply of AXIM Biotechnologies shares is 318.9M.
What is AXIM Biotechnologies Price to Earnings Ratio (PE Ratio)?
AXIM Biotechnologies PE Ratio is now.
What was AXIM Biotechnologies earnings per share over the trailing 12 months (TTM)?
AXIM Biotechnologies EPS is -0.02 USD over the trailing 12 months.
Which sector does the AXIM Biotechnologies company belong to?
The AXIM Biotechnologies sector is Healthcare.